- Home
- Publications
- Publication Search
- Publication Details
Title
Management Strategies for Recurrent Endometrial Cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2018-07-04
DOI
10.1080/14737140.2018.1491311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
- (2017) Ritu Salani et al. GYNECOLOGIC ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
- (2017) Helen J. MacKay et al. Oncotarget
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013
- (2017) Joannie Lortet-Tieulent et al. JNCI-Journal of the National Cancer Institute
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer
- (2016) V N Sivalingam et al. BRITISH JOURNAL OF CANCER
- A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)
- (2016) Vicky Makker et al. CANCER
- The role of surgery in recurrent endometrial cancer
- (2016) Valentina Zanfagnin et al. Expert Review of Anticancer Therapy
- Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study
- (2016) Brandon-Luke L. Seagle et al. GYNECOLOGIC ONCOLOGY
- Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma
- (2016) Yiqing Xu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer
- (2016) Ana-Maria Schmidt et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of resource utilization using time-derived, activity-based costing (TDABC) to result in more effective processes and cost reduction.
- (2016) Pamela T. Soliman et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
- (2016) Zhongfu Mo et al. Oncology Letters
- Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy
- (2016) Shaakir Hasan et al. Frontiers in Oncology
- Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift
- (2015) Andrea Papadia et al. ANNALS OF SURGICAL ONCOLOGY
- Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
- (2015) Tjalling Bosse et al. EUROPEAN JOURNAL OF CANCER
- Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer
- (2015) Scott McMeekin et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2015) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Patterns and utility of routine surveillance in high grade endometrial cancer
- (2015) Jessica Hunn et al. GYNECOLOGIC ONCOLOGY
- Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
- (2015) Ursula Matulonis et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial
- (2015) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study 0229N
- (2015) Vicky Makker et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2015) David Bender et al. GYNECOLOGIC ONCOLOGY
- Management of nodal recurrences of endometrial cancer with IMRT
- (2015) Jennifer C. Ho et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA)
- (2015) Fiona Simpkins et al. GYNECOLOGIC ONCOLOGY
- Salvage Cytoreductive Surgery for Recurrent Endometrial Cancer
- (2015) Taner Turan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Second-Line Therapy for Endometrial Cancer: The Need for Better Options
- (2015) Gini F. Fleming JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma
- (2015) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
- (2014) Akira Mitsuhashi et al. CANCER
- Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer
- (2014) Daliah Tsoref et al. GYNECOLOGIC ONCOLOGY
- Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
- (2014) Ido Laskov et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia
- (2014) Vincent Castonguay et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
- (2014) Don S. Dizon et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
- (2014) Matthew A. Powell et al. GYNECOLOGIC ONCOLOGY
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
- (2014) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
- (2013) N Colombo et al. BRITISH JOURNAL OF CANCER
- Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
- (2013) I Ray-Coquard et al. BRITISH JOURNAL OF CANCER
- Phase II study of fulvestrant 250mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
- (2013) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study
- (2013) Kimberly K. Leslie et al. GYNECOLOGIC ONCOLOGY
- Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study
- (2013) Shoji Nagao et al. GYNECOLOGIC ONCOLOGY
- Treatment of Advanced or Recurrent Endometrial Carcinoma With Doxorubicin in Patients Progressing After Paclitaxel/Carboplatin
- (2013) Vicky Makker et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study
- (2012) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer
- (2012) Kimberly K. Leslie et al. GYNECOLOGIC ONCOLOGY
- Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (2012) D. Miller et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
- (2012) Edwin A. Alvarez et al. GYNECOLOGIC ONCOLOGY
- The Clinical Relevance of Rising CA-125 Levels Within the Normal Range in Patients With Uterine Papillary Serous Cancer
- (2012) Marina Frimer et al. Reproductive Sciences
- Pelvic exenteration with curative intent for recurrent uterine malignancies
- (2011) Fady Khoury-Collado et al. GYNECOLOGIC ONCOLOGY
- Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer
- (2011) Alessia Di Legge et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
- (2011) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Endometrial Cancer Incidence Rates in the United States, 1999–2006
- (2011) Linh M. Duong et al. JOURNAL OF WOMENS HEALTH
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
- (2010) Brian M. Slomovitz et al. CANCER
- A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia
- (2010) Halla S. Nimeiri et al. GYNECOLOGIC ONCOLOGY
- Cytoreductive surgery for advanced or recurrent endometrial cancer: A meta-analysis
- (2010) Joyce N. Barlin et al. GYNECOLOGIC ONCOLOGY
- A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study
- (2010) David L. Tait et al. GYNECOLOGIC ONCOLOGY
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology
- (2009) David Scott Miller et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
- (2009) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P
- (2009) Don S. Dizon et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group
- (2008) Agustin A. Garcia et al. GYNECOLOGIC ONCOLOGY
- Rationale for folate receptor alpha targeted therapy in “high risk” endometrial carcinomas
- (2008) Monica Brown Jones et al. INTERNATIONAL JOURNAL OF CANCER
- A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer
- (2008) Howard D. Homesley et al. International Journal of Clinical Oncology
- Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148
- (2008) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More